Schond Greenway From cell therapy to precision medicine, Schond Greenway has hopped from one burgeoning research area to the next throughout his career. Now he’s heading off to another: psychedelic therapy.
MindMed tapped Greenway as CFO on Monday, as CEO Robert...
Click to view original post
